Friday, 16 October 2026European Markets

BURELLE, CHRISTIAN DIOR, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Consumer Cyclical Sector.

Loading stream...

(vianews) - burelle (bur.pa) is among this list of stock assets with the highest dividend rate and return on equity on the consumer cyclical sector.

financial asset price forward dividend yield return on equity
burelle (bur.pa) €484.00 3.21% 4.63%
christian dior (cdi.pa) €845.50 1.44% 29.21%
renault (rno.pa) €32.81 0.76% 5.64%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. burelle (bur.pa)

3.21% forward dividend yield and 4.63% return on equity

burelle sa, through its subsidiaries, offers automotive equipment, intelligent body systems, and clean energy systems and modules in france and internationally. the company offers plastic and composite body parts and systems, and fuel and pollution control systems; researches and develops lightweight vehicles, pollution control systems, and support for new engines; and develops, assembles, and provides logistics for automotive front-end modules. it also operates a venture capital company that invests in various companies through a network of family offices, investment funds, and financial institutions; and owns an office building in levallois, as well as various real estate assets in the lyon region. burelle sa was founded in 1957 and is headquartered in lyon, france.

earnings per share

as for profitability, burelle has a trailing twelve months eps of €71.96.

pe ratio

burelle has a trailing twelve months price to earnings ratio of 6.73. meaning, the purchaser of the share is investing €6.73 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.63%.

revenue growth

year-on-year quarterly revenue growth grew by 3.6%, now sitting on 7.38b for the twelve trailing months.

more news about burelle.

2. christian dior (cdi.pa)

1.44% forward dividend yield and 29.21% return on equity

christian dior se, through its subsidiaries, engages in the production, distribution, and retail of fashion and leather goods, wines and spirits, perfumes and cosmetics, and watches and jewelry worldwide. the company offers its fashion and leather goods under the louis vuitton, fendi, celine, loewe, givenchy, kenzo, berluti, pucci, loro piana, rimowa, and off-white brand names; and wines and spirits under the hennessy, moët & chandon, dom pérignon, veuve clicquot, krug, château d'yquem, belvedere, glenmorangie, newton vineyards, bodega numanthia, château d'esclans, armand de brignac, and joseph phelps brands. it also provides perfumes and cosmetics under the parfums christian dior, guerlain, parfums givenchy, make up for ever, benefit cosmetics, fresh, acqua di parma, kvd vegan beauty, fenty, ole henriksen, maison francis kurkdjian, and officine universelle buly 1803 brand names; and watches and jewelry under the tiffany, bulgari, tag heuer, zenith, hublot, chaumet, fred, and repossi brands. in addition, the company operates retail stores under the dfs galleria, sephora, and le bon marché names; publishes le parisien-aujourd'hui en france, a daily newspaper; builds yachts; and operates hotel and the cova pastry shop brand. further, it is involved in real estate activities. the company sells its products through store network, including e-commerce websites; and agents and distributors. the company was incorporated in 1946 and is headquartered in paris, france. christian dior se was formerly a subsidiary of financière agache société anonyme.

earnings per share

as for profitability, christian dior has a trailing twelve months eps of €32.13.

pe ratio

christian dior has a trailing twelve months price to earnings ratio of 26.31. meaning, the purchaser of the share is investing €26.31 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 29.21%.

more news about christian dior.

3. renault (rno.pa)

0.76% forward dividend yield and 5.64% return on equity

renault sa engages in the design, manufacture, sale, repair, maintenance, and leasing of motor vehicles in europe, eurasia, africa, the middle east, the asia pacific, and the americas. it also engages in the design and production of parts and equipment used for manufacturing and operating vehicles. the company operates through automotive, sale financing, and mobility services segments. its automotive segment produces, sells, and distributes passenger cars and light commercial vehicles; and invests in automotive-sector associates and joint ventures primarily in nissan. the company's sale financing segment offers sale financing, leasing, maintenance, and services contract under the mobilize financial services brand. its mobility services segment provides mobility and energy solutions for electric vehicle users under the mobilize brand. in addition, it is also involved in the design, manufacture, and sale of passenger cars and light commercial vehicles and innovative services under the renault, dacia, alpine, and mobilize brands. further, the company offers used vehicles and spare parts; and engages in business to business powertrain activities, including exchange of powertrain parts and related engineering activities. renault sa was founded in 1898 and is based in boulogne-billancourt, france.

earnings per share

as for profitability, renault has a trailing twelve months eps of €6.07.

pe ratio

renault has a trailing twelve months price to earnings ratio of 5.41. meaning, the purchaser of the share is investing €5.41 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.64%.

more news about renault.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com